Kaken Pharmaceutical
Clinical trials sponsored by Kaken Pharmaceutical, explained in plain language.
-
Scientists test new Drug's hidden effects on your daily coffee and medicine
Knowledge-focused CompletedThis study aimed to understand how an experimental drug called KP-001 might interact with other common substances in the body. Researchers gave KP-001 to 38 healthy volunteers along with a cholesterol medication (rosuvastatin) and caffeine to see if it changed how these substance…
Phase: PHASE1 • Sponsor: Kaken Pharmaceutical • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test new Drug's heart safety in healthy volunteers
Knowledge-focused CompletedThis study aimed to see if an experimental drug called KP-001 affects the electrical rhythm of the heart. It involved 40 healthy adult volunteers who received different doses of KP-001, a placebo (inactive substance), and a comparison drug. The main goal was to measure the drug's…
Phase: PHASE1 • Sponsor: Kaken Pharmaceutical • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Scientists test new Drug's safety in people with liver issues
Knowledge-focused CompletedThis study tested how a new drug called KP-001 is processed by the body in people with different levels of liver problems. Researchers gave a single dose to 24 adults, including healthy volunteers and people with mild to severe liver impairment. The goal was to see if liver probl…
Phase: PHASE1 • Sponsor: Kaken Pharmaceutical • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC